Ferraccioli, GianFranco <br/><br/>
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids.  [electronic resource] 

 -  Acta diabetologica  Sep 2008 
 - 195-6 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1432-5233 
<br/><br/><label>Standard No.: </label>10.1007/s00592-008-0036-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antirheumatic Agents--therapeutic use<br/>B-Lymphocytes--pathology<br/>Combined Modality Therapy<br/>Cyclosporine--therapeutic use<br/>Diabetes Mellitus, Type 1--complications<br/>Drug Delivery Systems<br/>Female<br/>Humans<br/>Immunosuppression Therapy--methods<br/>Immunosuppressive Agents--therapeutic use<br/>Leukapheresis--methods<br/>Lupus Erythematosus, Systemic--complications<br/>Rituximab<br/>T-Lymphocytes--drug effects<br/>Treatment Outcome